These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26492539)

  • 1. Simulation of Human Plasma Concentrations of Thalidomide and Primary 5-Hydroxylated Metabolites Explored with Pharmacokinetic Data in Humanized TK-NOG Mice.
    Nishiyama S; Suemizu H; Shibata N; Guengerich FP; Yamazaki H
    Chem Res Toxicol; 2015 Nov; 28(11):2088-90. PubMed ID: 26492539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.
    Yamazaki H; Suemizu H; Shimizu M; Igaya S; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
    Chem Res Toxicol; 2012 Feb; 25(2):274-6. PubMed ID: 22268628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiles of pomalidomide in human plasma simulated with pharmacokinetic data in control and humanized-liver mice.
    Shimizu M; Suemizu H; Mitsui M; Shibata N; Guengerich FP; Yamazaki H
    Xenobiotica; 2017 Oct; 47(10):844-848. PubMed ID: 27852146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of primary oxidative metabolites of thalidomide in rats and in chimeric mice humanized with different human hepatocytes.
    Miura T; Uehara S; Shimizu M; Suemizu H; Yamazaki H
    J Toxicol Sci; 2021; 46(7):311-317. PubMed ID: 34193768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathione conjugate.
    Chowdhury G; Murayama N; Okada Y; Uno Y; Shimizu M; Shibata N; Guengerich FP; Yamazaki H
    Chem Res Toxicol; 2010 Jun; 23(6):1018-24. PubMed ID: 20443640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice.
    Yamazaki H; Suemizu H; Igaya S; Shimizu M; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
    Chem Res Toxicol; 2011 Mar; 24(3):287-9. PubMed ID: 21299192
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Uehara S; Murayama N; Higuchi Y; Shimizu M; Suemizu H; Guengerich FP; Yamazaki H
    Chem Res Toxicol; 2024 May; 37(5):671-674. PubMed ID: 38626399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pharmacokinetic profiles of lenalidomide in human plasma simulated using pharmacokinetic data in humanized-liver mice with liver toxicity detected by human serum albumin RNA.
    Murayama N; Suemizu H; Uehara S; Kusama T; Mitsui M; Kamiya Y; Shimizu M; Guengerich FP; Yamazaki H
    J Toxicol Sci; 2018; 43(6):369-375. PubMed ID: 29877213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice.
    Yamazaki H; Suemizu H; Murayama N; Utoh M; Shibata N; Nakamura M; Guengerich FP
    Chem Res Toxicol; 2013 Mar; 26(3):486-9. PubMed ID: 23419139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of primary metabolites 5-hydroxythalidomide and 5'-hydroxythalidomide formed after oral administration of thalidomide in the rabbit, a thalidomide-sensitive species.
    Kuwagata M; Hasegawa T; Takashima H; Shimizu M; Kitajima S; Yamazaki H
    J Toxicol Sci; 2021; 46(12):553-560. PubMed ID: 34853241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology.
    Yamazaki H; Suemizu H; Mitsui M; Shimizu M; Guengerich FP
    Chem Res Toxicol; 2016 Dec; 29(12):1903-1911. PubMed ID: 27337115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.
    Okada Y; Murayama N; Yanagida C; Shimizu M; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 2009 Jan; 37(1):18-23. PubMed ID: 18948377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals.
    Uehara S; Higuchi Y; Yoneda N; Kawai K; Yamamoto M; Kamimura H; Iida Y; Oshimura M; Kazuki Y; Yamazaki H; Hikita H; Takehara T; Suemizu H
    Drug Metab Pharmacokinet; 2022 Feb; 42():100410. PubMed ID: 34839181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Protein Binding of 5-Hydroxythalidomide Bioactivated in Humanized Mice with Human P450 3A-Chromosome or Hepatocytes by Two-Dimensional Electrophoresis/Accelerator Mass Spectrometry.
    Yamazaki H; Suemizu H; Kazuki Y; Oofusa K; Kuribayashi S; Shimizu M; Ninomiya S; Horie T; Shibata N; Guengerich FP
    Chem Res Toxicol; 2016 Aug; 29(8):1279-81. PubMed ID: 27464947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probe drug T-1032 N-oxygenation mediated by cytochrome P450 3A5 in human hepatocytes in vitro and in humanized-liver mice in vivo.
    Uehara S; Shimizu M; Plé K; Routier S; Yoneda N; Higuchi Y; Suemizu H; Yamazaki H
    Drug Metab Pharmacokinet; 2022 Jun; 44():100453. PubMed ID: 35381575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide.
    Chowdhury G; Shibata N; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2014 Jan; 27(1):147-56. PubMed ID: 24350712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity.
    Murayama N; Kazuki Y; Satoh D; Arata K; Harada T; Shibata N; Guengerich FP; Yamazaki H
    J Toxicol Sci; 2017; 42(3):343-348. PubMed ID: 28496040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Roles of Human Cytochrome P450 2C9 and 3A Enzymes in Diclofenac 4'- and 5-Hydroxylations Mediated by Metabolically Inactivated Human Hepatocytes in Previously Transplanted Chimeric Mice.
    Miura T; Uehara S; Shimizu M; Murayama N; Utoh M; Suemizu H; Yamazaki H
    Chem Res Toxicol; 2020 Feb; 33(2):634-639. PubMed ID: 31854189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma metabolic profiles of benzydamine, a flavin-containing monooxygenase probe substrate, simulated with pharmacokinetic data from control and humanized-liver mice.
    Yamazaki-Nishioka M; Shimizu M; Suemizu H; Nishiwaki M; Mitsui M; Yamazaki H
    Xenobiotica; 2018 Feb; 48(2):117-123. PubMed ID: 28145791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
    Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
    Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.